trending Market Intelligence /marketintelligence/en/news-insights/trending/yKB0fDH1dSeRrIAvQZWUbg2 content esgSubNav
In This List

Loxo Oncology director resigns

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Loxo Oncology director resigns

David Bonita resigned as a class II independent director of Loxo Oncology Inc., effective Dec. 22.

Bonita's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices.